Testicular Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect testicular Cancer Information Center has current, evidence-based information for you. Get the facts about testicular cancer early detection, treatment, and survivorship, and stay up to date with ongoing testicular cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Testicular Cancer Community is the leading Social Media Application for Testicular Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
Join ongoing discussions with other individuals affected by testicular cancer in the CancerConnect private online testicular cancer support group OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine
Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition... Marriage May Have a Protective Effect for Cancer Patients
Married patients are less likely to present with metastatic disease, more likely to adhere to treatment protocols, and less likely to die from their disease.
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
Testicular Cancer Management
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer... Pay it Forward
Survivors become peer mentors to newly diagnosed women and offer experience, insight,...
Testicular Cancer Clinical Trials
REFMAL28-Ts – A PHASE I STUDY OF ORAL TEMOZOLOMIDE IN COMBINATION WITH IRINOTECAN IN PATIENT WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS.-Ts
REFMAL39 – A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
REFMAL30-TS – PHASE I, OPEN-LABEL, MULTI-DOSE, DOSE-ESCALATION STUDY OF GW572016 IN PATIENTS WITH SOLID TUMORS-TS